Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure — Stella

Home/Atrial Fibrillation/Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Poland

National Institute of Cardiology, Warsaw, Masovian Voivodeship

Key details

Phase

Post-approval study

Sponsor

National Institute of Cardiology, Warsaw, Poland

Collaborators

Medical Research Agency, Poland

Enrollment target

~200 participants

Started

January 2018

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.